What non‑controlled‑substance, non‑antipsychotic interventions can be used to treat agitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nonpharmacologic Interventions Are the Primary Alternative for Agitation Management

Prioritize person-centered nonpharmacologic approaches including individualized music therapy, tailored activity programs with social interaction, and multicomponent interventions as first-line treatment for agitation before considering any pharmacologic options. 1, 2, 3

Evidence-Based Nonpharmacologic Strategies

The most recent 2025 geriatric emergency guidelines explicitly state that nonpharmacologic approaches such as person-centered communication or sensory therapy are always preferred as both antipsychotics and anxiolytics pose significant risks including respiratory depression, dysrhythmia, hypotension, and exacerbation of delirium 1.

Highest Quality Evidence Supports:

Moderate-quality evidence (strongest available):

  • Individualized music therapy - Most consistent effects, particularly for verbal agitation 4, 3
  • Massage or touch therapy 3
  • Tailored activity programs with social interaction - Substantial evidence for effectiveness 5
  • Multicomponent interventions combining reorientation, cognitive stimulation, sleep optimization, early mobilization, and sensory aids 6, 3

Implementation approach:

  • Use person-centered assessment first to identify triggers and individual preferences 3
  • Implement structured environmental modifications: predictable routines, reduced stimulation, adequate lighting, removal of hazards 2
  • Apply the "three R's" strategy: Repeat, Reassure, Redirect 2

Specific Environmental Modifications That Work:

  • Establish predictable daily routines (meals, exercise, bedtime at same times) 2
  • Use color-coded labels and visual cues for orientation 2
  • Optimize lighting to reduce confusion and nighttime restlessness 2
  • Minimize environmental triggers: reduce noise, avoid crowded places, eliminate clutter 2
  • Scheduled toileting to prevent agitation from discomfort 2

Critical Pitfalls to Avoid

Do NOT use benzodiazepines - The 2025 JAGS guidelines found midazolam posed excessive risk with 53% adverse event rate (OR 5.25 vs haloperidol), and lorazepam showed dose-dependent increased adverse events 1. Benzodiazepines are controlled substances and contraindicated based on your criteria.

Avoid premature pharmacologic intervention - The 2016 APA guidelines explicitly recommend reviewing clinical response to nonpharmacologic interventions prior to any medication use 7. Implementation of person-centered care at the organizational level enhances effectiveness of subsequent interventions 3.

When Nonpharmacologic Approaches Are Insufficient

If severe, dangerous agitation persists despite exhausting nonpharmacologic strategies, the evidence shows oral quetiapine had the lowest adverse event frequency (OR 0.27 vs haloperidol) among medications studied 1. However, quetiapine is an antipsychotic, which you've excluded.

The reality: There are no non-controlled, non-antipsychotic pharmacologic agents with strong evidence for acute severe agitation. The 2025 guidelines evaluated only antipsychotics, benzodiazepines (controlled), and ketamine (controlled) because these are the only medication classes with evidence 1.

Alternative Pharmacologic Considerations (Limited Evidence)

For chronic agitation in dementia specifically (not acute):

  • Trazodone 25-400mg daily - mood stabilizer with antiagitation properties, though evidence is from older 2002 guidelines 2
  • Divalproex sodium - better tolerated than other mood stabilizers, requires monitoring 2
  • SSRIs (citalopram, sertraline) - for agitation associated with depression in dementia 2

These have minimal evidence for acute agitation and are primarily used for chronic behavioral management in dementia populations.

Practical Algorithm

  1. Immediate assessment: Identify and treat pain, medical causes (infection, constipation, medication effects) 7
  2. Environmental intervention: Implement structured routine, reduce triggers, optimize sensory environment 2
  3. Person-centered strategies: Use individualized music, meaningful activities, touch therapy 3, 5
  4. Multicomponent bundle: Combine cognitive stimulation, sleep hygiene, early mobilization, sensory aids 6
  5. Only if severe/dangerous AND nonpharmacologic failure: Consider medication consultation, but recognize this requires antipsychotics or controlled substances for evidence-based acute management 1

The evidence unequivocally demonstrates that nonpharmacologic interventions must be the foundation of agitation management, with pharmacologic options reserved for severe cases where safety is immediately threatened 1, 7, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.